NCT05905653已完成1 期
Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Maximum Plasma Concentration [Cmax]
研究概览
简要总结
To evaluate the safety and plasma pharmacokinetics of STN1012600 ophthalmic solution 0.002% (1 drop once daily for 7 days) in healthy adult male subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 35 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Subjects who can comply with scheduled visits and the examination and observation as specified in the clinical study protocol
排除标准
- •Subjects have a disease and/or abnormal laboratory value which is considered inappropriate from safety evaluation perspective
- •Subjects who are inappropriate as participants in this study in the opinion of the investigator or sub investigator
研究组 & 干预措施
STN1012600 0.002%
Experimental
干预措施: STN1012600 ophthalmic solution 0.002% (Drug)
结局指标
主要结局
Maximum Plasma Concentration [Cmax]
时间窗: 1 week, Day 1 and Day 7
Calculate plasma pharmacokinetic parameters and study pharmacokinetics.
次要结局
- Area Under The Curve From Time Zero to the Last Sampling Time [AUC 0-t](1 week, Day 1 and Day 7)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A research study of a new medicine NNC0519-0130 in Japanese and non-Japanese metype 2 diabetesJPRN-jRCT2071230015Tsukasaki Nobuaki70
招募中
1 期
A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-399, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors-JPRN-jRCT2080225128-6
进行中（未招募）
1 期
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV)in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-Positive. Revised Protocol 02, incorporating Protocol Amendment 01 (v1.0, date 18-Apr-2008), and Protocol Amendment 04 (v1.0, date 05-Dec-2008).Chronic Hepatitis B Virus (HBV) InfectionMedDRA version: 8.1Level: LLTClassification code 10019743Term: Hepatitis B virus (HBV)EUCTR2005-005816-26-BEBristol-Myers Squibb International Corporation64
进行中（未招募）
1 期
A study of Entecavir in Pediatric Patients with Chronic Hepatitis B Virus (HBV) InfectioChronic Hepatitis B Virus (HBV) InfectionMedDRA version: 16.1 Level: LLT Classification code 10019743 Term: Hepatitis B virus (HBV) System Organ Class: 100000004848EUCTR2005-005816-26-GBBristol-Myers Squibb International Corporation64
进行中（未招募）
不适用
A study of Entecavir in Pediatric Patients with Chronic Hepatitis B Virus (HBV) InfectioEUCTR2005-005816-26-Outside-EU/EEABristol-Myers Squibb International Corporation64